Prophylaxis and Treatment of Invasive Mold Infections
Originally presented at HOPA's 14th Annual Conference, March 2018.
This session will involve a spirited debate about newer data in the field of prophylaxis and management of invasive mold infections. Emphasis will be placed on antifungal therapies in the hematologic malignancy population.
Jim Lewis, PharmD FIDSA; Bernard Marini PharmD BCOP; Anthony Perissinotti, PharmD BCOP
Patient Management & Therapeutics
The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. An ACPE statement of credit will be issued only upon completion of the pre/post- assessment and a post-activity evaluation form. ACPE credit must be claimed by March 22, 2021.
This activity has been approved for .125 CEU
This course is also included as part of the Best of 2018 Annual Conference Recordings Bundle.
Release Date: September 26, 2018
Expiration Date: March 22, 2021